Lixte Biotechnology Holdings Inc (NASDAQ: LIXT) is -14.77% lower on its value in year-to-date trading and has touched a low of $0.64 and a high of $3.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LIXT stock was last observed hovering at around $1.18 in the last trading session, with the day’s gains setting it 243268.82%.
Currently trading at $243270.0, the stock is 81.99% and 65.41% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 37.96 million and changing 71.19% at the moment leaves the stock 22.78% off its SMA200. LIXT registered -0.48% loss for a year compared to 6-month loss of 1.00%. The firm has a 50-day simple moving average (SMA 50) of $1.2214 and a 200-day simple moving average (SMA200) of $1.6453.
The stock witnessed a 43.26% gain in the last 1 month and extending the period to 3 months gives it a 69.04%, and is 159.31% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 43.38% over the week and 21.87% over the month.
Lixte Biotechnology Holdings Inc (LIXT) has around 2 employees, a market worth around $5.43M and $0.00M in sales. Distance from 52-week low is 215.63% and -32.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-286.78%).
11.0 institutions hold shares in Lixte Biotechnology Holdings Inc (LIXT), with institutional investors hold 19.42% of the company’s shares. The shares outstanding are 2.68M, and float is at 2.08M with Short Float at 0.21%. Institutions hold 15.84% of the Float.
